Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke (RECOMBINE)

September 18, 2017 updated by: Dr. med. Carlo Cereda

Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke to Increase Upper Limb Motor Recovery, a Randomised, Controlled, Double-blind Study

Rehabilitation after stroke improves motor functions by promoting plastic changes however, after completing standard rehabilitation, 50-60% of patients still exhibit some degree of motor impairment and require at least partial assistance in activities of day living. Therefore, the exploration of other approaches to promote recovery is compulsory. Non invasive brain stimulation and motor rehabilitation are thought to share similar mechanisms in inducing neuroplastic changes in the human cortex and an emerging field of research is focusing on the possibility of coupling both therapies in order to achieve an additive effect and improve outcome.

We hypothesize that coupling bihemispheric transcranial direct current stimulation (tDCS) with simultaneous physical/occupational therapy in the subacute phase of ischemic stroke patients may improve upper limb motor recovery in humans.

This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial. Thirty-six ischemic stroke patients in the subacute phase will be recruited in three centers of neurorehabilitation in Switzerland. After stratification based on the Fugl-Meyer Assessment Upper Extremity according to the severity of the deficit, the patient will be randomized to receive besides standardized physical/occupational treatment according to the Impairment-Oriented Training, tDCS of themotor cortex (1.5 mA, 30 minutes) (group 1: 12 patients) or sham stimulation (without current) (group 2: 12 patients). After three weeks of treatment group 1 and 2 will cross-over and will be treated for other three weeks. Group 3 (12 patients) will receive routine physical/occupational treatment and sham tDCS for six weeks. Assessment will be performed before starting tDCS, at week 3, 6 and at 6 months. Outcome measures are the Fugl-Meyer Assessment Upper Extremity, the extended Barthel Index, the Ashworth scale, the Test of Upper Limb Apraxia (only baseline, week 6, month6), the grip strength evaluated by the Jamar Hydraulic Hand dynamometer. At baseline at week 6 and at month 6 depression will be assessed by the Hamilton depression Rating Scale.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bern, Switzerland, 3010
        • Withdrawn
        • Universitätsspital Bern, Inselspital, Neuropsychologische Rehabilitation
      • Brissago, Switzerland, 6614
        • Recruiting
        • Clinica Hildebrand, Centro di riabilitazione Brissago
        • Contact:
        • Principal Investigator:
          • Paolo Rossi, MD
      • Zihlschlacht, Switzerland, 8588
        • Terminated
        • HELIOS Klinik Zihlschlacht AG, Neurologisches Rehabilitationszentrum

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Ischemic lesions in the territory of middle cerebral artery subcortical or subcortical/cortical confirmed neuroimaging
  2. Inclusion must be in the sub-acute phase defined as within 2-4 weeks after stroke
  3. Persistent hemiparesis, indicated by a score of 1-3 on the motor arm item of the NIH Stroke Scale (NIHSS) (Brott et al. 1989) but wrist and finger movement is not required
  4. No UE injury or conditions that limited use prior to the stroke.
  5. The patient is >18 years old.
  6. The patient has subscribed the informed consent

Exclusion Criteria:

  1. History of epilepsy, brain tumor, major head trauma, learning disorder, severe cognitive impairment, drug or alcohol abuse, major psychiatric illness
  2. Use of medications that may lower seizure threshold (e.g., metronidazole, fluoroquinolones)
  3. Severe pain in the affected upper limb (>=8 on the shoulder item of the "joint pain during passive motion" of the Fugl-Meyer Assessment Upper Extremity)
  4. Further stroke or other significant medical complication during the study
  5. Evidence of severe leucoencephalopathy (grade IV according to the Fazeka's scale)
  6. Important aphasia that would impair the understanding and performance of the assessment scales

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1 tDCS-Sham
tDC stimulation for 3 weeks, then cross-over to sham stimulation
Anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks, then sham stimulation for 30 seconds on 15 days during 3 weeks
Experimental: 2 Sham-tDCS
Sham stimulation for 3 weeks, then cross over to tDCS stimulation
Sham stimulation for 30 seconds on 15 days during 3 weeks, then anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks
Sham Comparator: 3 Sham-Sham
Treatment for 6 weeks daily with sham stimulation
Sham stimulation for 30 seconds on 15 days during 6 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Assessment Upper Extremity
Time Frame: 6 weeks
Investigator administered questionnaire
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Assessment Upper Extremity
Time Frame: 3 weeks
Investigator administered questionnaire
3 weeks
Fugl-Meyer Assessment Upper Extremity
Time Frame: 6 months
Investigator administered questionnaire
6 months
Barthel Index
Time Frame: 3 weeks
Investigator administered questionnaire
3 weeks
Barthel Index
Time Frame: 6 weeks
Investigator administered questionnaire
6 weeks
Barthel Index
Time Frame: 6 months
Investigator administered questionnaire
6 months
Ashworth scale
Time Frame: 3 weeks
Investigator administered questionnaire
3 weeks
Ashworth scale
Time Frame: 6 weeks
Investigator administered questionnaire
6 weeks
Ashworth scale
Time Frame: 6 months
Investigator administered questionnaire
6 months
Test of Upper Limb Apraxia (TULIA)
Time Frame: 6 weeks
investigator administered questionnaire
6 weeks
Test of Upper Limb Apraxia (TULIA)
Time Frame: 6 months
investigator administered questionnaire
6 months
Grip strength
Time Frame: 3 weeks
Jamar Hydraulic Hand dynamometer
3 weeks
Grip strength
Time Frame: 6 weeks
Jamar Hydraulic Hand dynamometer
6 weeks
Grip strength
Time Frame: 6 months
Jamar Hydraulic Hand dynamometer
6 months
Hamilton depression Rating scale
Time Frame: 6 weeks
Patient administered questionnaire
6 weeks
Hamilton depression Rating scale
Time Frame: 6 months
Patient administered questionnaire
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Carlo Cereda, MD, Ospedale Regionale di Lugano - Civico

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (Anticipated)

February 1, 2018

Study Completion (Anticipated)

February 1, 2018

Study Registration Dates

First Submitted

July 17, 2012

First Submitted That Met QC Criteria

July 17, 2012

First Posted (Estimate)

July 19, 2012

Study Record Updates

Last Update Posted (Actual)

September 19, 2017

Last Update Submitted That Met QC Criteria

September 18, 2017

Last Verified

September 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ischemic Stroke

Clinical Trials on transcranial direct current stimulation (tDCS)

3
Subscribe